Clare Sun
30PUBLICATIONS
121CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (30)
Sort by Publication Date:
|Dec 17, 2025
A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.Andy Itsara, Victoria M Rogness, Laura Samples
|Feb 20, 2025
Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy.Christine Gruessner, Adrian Wiestner, Clare Sun
|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta
|Sep 21, 2023
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.Emily Tomasulo, Shira Paul, Rui Mu
|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.Anfal Alsadhan, Jonathan Chen, Erika M Gaglione
|May 23, 2023
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.Maissa Mhibik, Erika M Gaglione, David Eik
Pageof 5
Frequent Collaborators
6 joint publications
Erika M Gaglione
5 joint publications
Inhye E Ahn
4 joint publications
Adrian Wiestner
4 joint publications
Christopher Pleyer
3 joint publications
Donna S Neuberg
3 joint publications
Catherine J Wu
3 joint publications
Xin Tian
2 joint publications
Maria Joao Baptista
2 joint publications
Maissa Mhibik
2 joint publications
Jennifer R Brown
